Booz Allen Hamilton Holding Corporation vs Novartis AG — how do they compare? Booz Allen Hamilton Holding Corporation trades at $78.57 (market cap $9.45B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 31.3× Booz Allen Hamilton Holding Corporation's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| BAH | NVS | |
|---|---|---|
Market Cap | $9.45B | $295.37B |
Sector | Industrials | Health |
52-Week High | $111.63 | $168.62 |
52-Week Low | $59.71 | $119.31 |
Enterprise Value | $13.07B | $336.69B |
Dividend Yield | 3% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Read more on BAH →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →